Østergaard, Mikkel
Haavardsholm, Espen A.
Article History
First Online: 2 September 2016
Competing interests
: M.Ø. declares that he has received research support and/or consultancy or speaker fees from Abbvie, Bristol-Myers Squibb, Boehringer-Ingelheim, Celgene, Eli Lilly, Centocor, GlaxoSmithKline, Hospira, Janssen, Merck, Mundipharma, Novartis, Novo, Orion, Pfizer, Regeneron, Schering-Plough, Roche, Takeda, UCB and Wyeth. E.H. declares no competing interests.